8‐ iso ‐prostaglandin E 2 induces nasal obstruction via thromboxane receptor in murine model of allergic rhinitis

2021 ◽  
Vol 35 (10) ◽  
Author(s):  
Tatsuro Nakamura ◽  
Yuri Tachibana ◽  
Takahisa Murata
2021 ◽  
Vol 141 ◽  
pp. 111944
Author(s):  
Susanna Choi ◽  
Myung-A Jung ◽  
Youn-Hwan Hwang ◽  
Bo-Jeong Pyun ◽  
Joo Young Lee ◽  
...  

ORL ◽  
2021 ◽  
pp. 1-6
Author(s):  
Giancarlo Pecorari ◽  
Giuseppe Riva ◽  
Claudia Bartoli ◽  
Mattia Ravera ◽  
Valeria Dell’Era ◽  
...  

Introduction: Radiofrequency turbinate volume reduction (RFTVR) is an effective treatment of inferior turbinate hypertrophy. RFTVR can reduce epithelial cell alterations in nasal mucosa. The aim of this observational study was to evaluate the effects of RFTVR on nasal obstruction and cytology, stratifying for different types of rhinitis. Methods: Nasal cytology and subjective nasal obstruction were evaluated on 113 patients before RFTVR (T0) and after 3 months (T1). The patients were divided into groups on the basis of the underlying disease: allergic rhinitis, nonallergic rhinitis, rhinitis medicamentosa, and other diseases (e.g., hormonal-based turbinate hypertrophy). Results: Nasal cytology at T0 identified 42 patients with allergic rhinitis, 40 with nonallergic rhinitis, 19 with rhinitis medicamentosa, and 12 with other diseases. An improvement of nasal cytology at T1 was observed in 29.2% of cases. They mainly consisted of patients with nonallergic rhinitis with neutrophils, whose neutrophil infiltrate decreased. Only 2 cases (1.7%) showed a worsening of nasal cytology at T1. A statistically significant decrease in subjective nasal obstruction was observed for every group (p < 0.05). Higher differences of nasal obstruction between T0 and T1 were found in patients with rhinitis medicamentosa or other diseases. Conclusion: RFTVR represents a safe and effective treatment for turbinate hypertrophy of various etiology. It is not responsible for a worsening of inflammatory infiltrate of the nasal mucosa.


2019 ◽  
Vol 59 (6) ◽  
pp. 434-439
Author(s):  
M. Mayo-Yáñez ◽  
J. Villares-Soriano ◽  
C. Calvo-Henríquez ◽  
JC. Vázquez-Barro ◽  
J. Herranz González-Botas ◽  
...  

2015 ◽  
Vol 31 (3) ◽  
pp. 391-396 ◽  
Author(s):  
Anna Maria Zicari ◽  
Francesca Occasi ◽  
Montanari Giulia ◽  
Luciana Indinnimeo ◽  
Giovanna De Castro ◽  
...  

2021 ◽  
Vol 8 (30) ◽  
pp. 2778-2783
Author(s):  
Nikhila Rajendran ◽  
Jaya C ◽  
Venugopal M ◽  
Satheesh S

BACKGROUND Nasal obstruction secondary to inferior turbinate hypertrophy significantly affects the quality of life. Patients refractory to medical treatment are taken up for surgery. Laser turbinate reduction is an effective and simple method for treatment of nasal obstruction due to inferior turbinate hypertrophy. Only a few studies reported on the outcome of laser inferior turbinate reduction in India. The present study was done to assess the clinical outcome of laser inferior turbinate reduction in patients with nasal obstruction due to inferior turbinate hypertrophy. METHODS This prospective observational study was done in 31 patients (18 – 60 years) with nasal obstruction due to inferior turbinate hypertrophy refractory to medical management who underwent laser inferior turbinate reduction in ENT Department, Government Medical College, Thiruvananthapuram from December 2017 to September 2019. RESULTS All patients had bilateral inferior turbinate hypertrophy. 21 out of 31 patients had allergic rhinitis and rest had non-allergic rhinitis. Pre-operatively most patients had symptom score between 15 and 20. After CO2 laser inferior turbinate reduction at the end of 3 months of follow up, subjective assessment by symptom scoring confirmed by objective assessment by flowmetry 29 out of 31 patients had good outcome with relief from nasal obstruction. The success rate was more in nonallergic rhinitis (100 %) than the allergic rhinitis group (90.47 %). CONCLUSIONS CO2 laser inferior turbinate reduction is an effective procedure to relieve nasal obstruction in patients with inferior turbinate hypertrophy refractory to medical treatment, with minimal complications. Post-procedure on follow up significant number of patients had relief from hyposmia, sneezing and running nose. KEYWORDS Nasal Obstruction, Peak Nasal Inspiratory Flowmetry, Symptom Scoring, CO2 Laser, Outcome


2002 ◽  
Vol 110 (6) ◽  
pp. 891-898 ◽  
Author(s):  
Christine McCusker ◽  
Martin Chicoine ◽  
Qutayba Hamid ◽  
Bruce Mazer

2014 ◽  
Vol 133 (2) ◽  
pp. AB134
Author(s):  
Daisuke Kajiwara ◽  
Hiroki Aoyagi ◽  
Kazuhiko Shigeno ◽  
Katsunao Tanaka ◽  
Eiji Sasaki ◽  
...  

2009 ◽  
Vol 7 (3) ◽  
pp. 153-160 ◽  
Author(s):  
G. Ciprandi ◽  
A. Pistorio ◽  
M.A. Tosca ◽  
I. Cirillo ◽  
G.L. Marseglia

A remarkable relationship exists between upper and lower airways. Bronchial obstruction is a paramount feature of asthma as well as nasal obstruction of allergic rhinitis (AR). This study aims to evaluate the response to both bronchodilation and decongestion testing and their relationships in a large group of patients with moderate-severe persistent AR alone. Two hundred eleven patients with moderate-severe persistent AR were prospectively and consecutively evaluated. Clinical examination, skin prick test, spirometry, bronchodilation test, rhinomanometry, and decongestion test were performed on all patients. Seventeen subjects (8%) did not respond to any of the tests, 55 subjects (26.1%) were responders only to the decongestion test, 31 (14.7%) only to the bronchodilation test, and 108 subjects (51.2%) responded to both these tests. Longer AR duration was significantly associated with positive response to both tests (p<0.01). In conclusion, this study provides the first evidence that patients with moderate-severe persistent AR may frequently show reversibility to both bronchodilation and decongestion tests.


2017 ◽  
Vol 12 (2) ◽  
pp. 38-40
Author(s):  
Adriana TUDOSE ◽  
◽  
Radu MATEESCU ◽  
Alexandru MATEI ◽  
Edu ANTOINE ◽  
...  

Allergic rhinitis is a chronic inflammation produced by the action of IgE antibodies which fight against allergens inside the mucosal nazale. It is characterized by symptoms such as nasal obstruction and/or watery rhinorrhea, sneezing and itching. Pregnancy is a temporary testing contraindication. During the pregnancy to detect the allergens involved in the symptoms we advise you to only take in vitro tests. The best approach in the management of rhinitis is to avoid allergens. Patients with mild to moderate rhinitis can only control the symptoms using nasal saline solution administered topically. Antihistamines can be useful during the pregnancy. Immunotherapy has not been found to be teratogenic and is clinically useful in relieving symptoms. The usage of oral decongestans and/or topical is controversial.


Sign in / Sign up

Export Citation Format

Share Document